logo

Onconova Therapeutics, Inc (ONTX)



Trade ONTX now with
  Date
  Headline
1/7/2021 9:41:44 AM Onconova Therapeutics Reports $8.7 Mln Public Offering
12/21/2020 8:15:22 AM Onconova Report Receipt Of FDA Permission For Phase 1 Study To Proceed Under IND For ON 123300
9/21/2020 8:14:25 AM Onconova Begins Phase 1 Clinical Trial In China For ON 123300 By HanX Biopharmaceuticals
8/31/2020 8:06:32 AM Onconova Therapeutics Names James Marino As Chairman Of Board
8/24/2020 7:33:06 AM Onconova Therapeutics Says Phase 3 INSPIRE Trial Did Not Meet Primary Endpoint Of Improved Survival
7/27/2020 8:15:05 AM Onconova Submits Application For Rigosertib To Participate In Federally Funded Human Studies In COVID-19 Disease
1/23/2020 8:46:40 AM Onconova Therapeutics Regains Rights To Rigosertib In Greater China
12/17/2019 7:59:57 AM Onconova, Pint Pharma Announce Brazilian Health Authority Approval For Beginning INSPIRE Trial
12/6/2019 7:37:00 AM Inceptua Medicines Access And Onconova Announce Pre-approval Access Collaboration For Rigosertib Outside The US